A prospective randomized controlled trial of selective transarterial chemoembolization using drug-eluting beads loaded with epirubicin versus selective conventional transarterial chemoembolization using epirubicin-lipiodol for hepatocellular carcinoma: The JIVROSG-1302 PRESIDENT study.

Masafumi Ikeda,Yoshitaka Inaba,Toshihiro Tanaka,Shunsuke Sugawara,Yoshihisa Kodama,Takeshi Aramaki,Hiroshi Anai,Shinichi Morita,Yoshinori Tsukahara,Hiroshi Seki,Mikio Sato,Kenya Kamimura,Kimei Azama,Masakatsu Tsurusaki,Eiji Sugihara,Masaya Miyazaki,Miyuki Sone,Yasuaki Arai

A prospective randomized controlled trial of selective transarterial chemoembolization using drug-eluting beads loaded with epirubicin versus selective conventional transarterial chemoembolization using epirubicin-lipiodol for hepatocellular carcinoma: The JIVROSG-1302 PRESIDENT study.

2020

Masafumi Ikeda
Yoshitaka Inaba
Toshihiro Tanaka
Shunsuke Sugawara
Yoshihisa Kodama
Takeshi Aramaki
Hiroshi Anai
Shinichi Morita
Yoshinori Tsukahara
Hiroshi Seki
Mikio Sato
Kenya Kamimura
Kimei Azama
Masakatsu Tsurusaki
Eiji Sugihara
Masaya Miyazaki
Miyuki Sone
Yasuaki Arai

4518Background: Transarterial chemoembolization (TACE) with selective catheterization into the segmental or subsegmental hepatic arteries supplying HCC is often performed to achieve the complete lo...

Keywords:

Urology
Lipiodol
Epirubicin
drug eluting beads
Pathology
Hepatocellular carcinoma
Medicine
Randomized controlled trial

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations